Skip to content
10-Q

Quarterly Report

RENNOVA HEALTH, INC.

0001493152-23-041175

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 6, 2023 40.55B sh
Shares Diluted Q3 2023 · Sep 30, 2023 31.4B sh
Shares Diluted Q3 2023 · Sep 30, 2023 503.06B sh
Shares Diluted Q3 2023 · Sep 30, 2022 10.57B sh
Shares Diluted Q3 2023 · Sep 30, 2022 4.13B sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 $3.1M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$1.17M
Short Term Debt Q3 2023 · Sep 30, 2023 $8.22M
Short Term Debt Q3 2023 · Dec 31, 2022 $8.62M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $123.9K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $499.47K
Stockholders Equity Q3 2023 · Sep 30, 2023 −$27.56M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$29.09M
Current Liabilities Q3 2023 · Sep 30, 2023 $47.19M
Current Liabilities Q3 2023 · Dec 31, 2022 $49.31M
Total Liabilities Q3 2023 · Sep 30, 2023 $47.41M
Total Liabilities Q3 2023 · Dec 31, 2022 $49.67M
Current Assets Q3 2023 · Sep 30, 2023 $5.68M
Current Assets Q3 2023 · Dec 31, 2022 $6.36M
Total Assets Q3 2023 · Sep 30, 2023 $19.85M
Total Assets Q3 2023 · Dec 31, 2022 $20.57M
Eps Diluted Q3 2023 · Sep 30, 2023 $0.00
Eps Diluted Q3 2023 · Sep 30, 2023 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.08
Eps Basic Q3 2023 · Sep 30, 2023 $0.00
Eps Basic Q3 2023 · Sep 30, 2023 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 −$0.08
Sga Expense Q3 2023 · Sep 30, 2023 $2.28M
Sga Expense Q3 2023 · Sep 30, 2023 $6.85M
Sga Expense Q3 2023 · Sep 30, 2022 $1.81M
Sga Expense Q3 2023 · Sep 30, 2022 $5.26M
Net Income Q3 2023 · Sep 30, 2023 −$548.23K
Net Income Q3 2023 · Sep 30, 2023 $1.54M
Net Income Q3 2023 · Dec 31, 2022 −$334.99M
Net Income Q3 2023 · Sep 30, 2022 −$1.34M
Net Income Q3 2023 · Sep 30, 2022 −$4.11M
Operating Income Q3 2023 · Sep 30, 2023 −$600.97K
Operating Income Q3 2023 · Sep 30, 2023 $2.25M
Operating Income Q3 2023 · Sep 30, 2022 −$924.81K
Operating Income Q3 2023 · Sep 30, 2022 −$2.81M
Revenue Q3 2023 · Sep 30, 2023 $3.54M
Revenue Q3 2023 · Sep 30, 2023 $14.84M
Revenue Q3 2023 · Sep 30, 2022 $2.83M
Revenue Q3 2023 · Sep 30, 2022 $7.58M